drug
as of 2026-07-01Transdermal nicotine patch
transdermal nicotine patchTransdermal Nicotine Patch
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Massachusetts General Hospital
4 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Trials
4
Nicotine Effects on Endophenotypes of Schizophrenia
NCT01315002—Completed
The Effects of Nicotine on Cognition in Schizophrenia
NCT00383747Phase 4Completed
Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia
NCT00218218Phase 2Completed
The Effects of Nicotine Withdrawal on Reward Responsivity in Schizophrenia
NCT00373126Phase 4Completed
KOLs & investigators
4
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication
indication
indication
indication
KOL
A. Eden Evins, MD, MPH
personKOL score 5
Michael Wagner, Prof. Dr.
personKOL score —
Jennifer Tidey, PhD
personKOL score —
Wolfgang Maier, Prof. Dr.
personKOL score —